Connection

Nicola Mumoli to Risk Assessment

Back to Details
This is a "connection" page, showing publications Nicola Mumoli has written about Risk Assessment.
Nicola Mumoli
Connection Strength
0.055
Risk Assessment
  1. Dabigatran in nonvalvular atrial fibrillation: from clinical trials to real-life experience. J Cardiovasc Med (Hagerstown). 2017 Jul; 18(7):467-477.
    View in: PubMed
    Score: 0.031
  2. A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism. Thromb Res. 2018 05; 165:107-111.
    View in: PubMed
    Score: 0.008
  3. The involvement of pharmacies in the screening of undiagnosed atrial fibrillation. Intern Emerg Med. 2017 Dec; 12(8):1081-1086.
    View in: PubMed
    Score: 0.008
  4. Efficacy and safety of extended thromboprophylaxis for medically ill patients. A meta-analysis of randomised controlled trials. Thromb Haemost. 2017 02 28; 117(3):606-617.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.